United States · Investor

Janus Capital Group

Last cheque observed Sep 2015. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietGrowth equity

SeedSeries ASeries BArtificial IntelligenceHealth DiagnosticsProduct Search

Cheques on record
0%of best year0cheques in 12 months, 14 on record
Since the last cheque4066days00hrs00min00sec
Median round$60MRounds led0 of 14Exits2 from the portfolioMostly inUnited States, 93%
Pitch Janus Capital Group

Janus Capital Group highlights

  1. 01

    14 rounds on record

  2. 02

    Mostly Series D and Series B: 50% of its rounds

  3. 03

    2 exits from the portfolio

What they do

Type
Growth equity (from a list, unverified)
Cheque size
Not stated
Stages
SeedSeries ASeries BGrowthPre-IPO
Sectors
Artificial IntelligenceHealth DiagnosticsProduct Search
Based in
Denver, United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first14 appearances

  1. 2015

    6 rounds

  2. Sept
    AveXisSeries D · US$65MWith 11 others
  3. Sept
    Intellia TherapeuticsSeries B · US$70MWith 7 others
  4. Jun
    Clementia PharmaceuticalsSeries B · CA$60MWith 6 others
  5. May
    REGENXBIOSeries D · US$71MWith 12 others
  6. Apr
    Edge TherapeuticsSeries C · US$56MWith 5 others
  7. Jan
    Aduro BioTechSeries D · US$51MWith 1 other
  8. 2014

    2 rounds

  9. Jun
    OktaSeries E · US$75MWith 5 others
  10. Apr
    ProNAi TherapeuticsSeries D · US$60MWith 8 others
  11. 2013

    1 round

  12. May
    ApptioSeries E · US · finsmes.com$45MWith 6 others
  13. 2011

    1 round

  14. Oct
    WorkdaySeries F · US · marketwatch.com$85MWith 3 others
  15. 2009

    2 rounds

  16. Jun
    MediQuest TherapeuticsSeries B · US · onbiovc.com$23MWith 3 others
  17. Jun
    Portola PharmaceuticalsSeries C · US$60MWith 17 others
  18. 2006

    1 round

  19. Jun
    MediQuest TherapeuticsSeries A · US · mqti.com$16MWith 3 others
  20. 2005

    1 round

  21. Feb
    FibroGenSeries F · US · fibrogen.com$100MWith 14 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 13 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Exits from the portfolio

Companies it backed that were later bought or listed2 in all

Portola PharmaceuticalsListed$100MMay 2013
WorkdayListedUndisclosedOct 2012

An exit counts when it came after the firm's first round in the company. From historical deal records.

Companies it bought

Acquisitions by the firm itself

VelocityShares$30MDec 2014
VSHolding$30MOct 2014

Who they invest alongside

The investors most often in the same rounds as Janus Capital Group. A count of rooms they were both in, not a relationship either has claimed.

Quick answers about Janus Capital Group

What does Janus Capital Group invest in?

Janus Capital Group invests most often at Series D and Series B (50% of the rounds on record), in sectors such as Artificial Intelligence, Health Diagnostics and Product Search.

How active is Janus Capital Group?

14 investments on record, 0 of them in the last 12 months. The most recent was in Sept 2015.

How big are Janus Capital Group's cheques?

The median round it joins is $60M.

Does Janus Capital Group lead rounds?

Rarely, if at all: none of its 14 investments on record names it as the lead.

Where does Janus Capital Group invest?

Most of the companies it backs are in the United States (93%) and Canada (7%).

Is Janus Capital Group investing now?

No investments in the last 12 months; the latest was in Sept 2015.

Who does Janus Capital Group invest alongside?

Most often T. Rowe Price (5 rounds together), OrbiMed (4 rounds together) and Adage Capital Management (3 rounds together).

What kind of investor is Janus Capital Group?

Janus Capital Group is a growth equity firm based in Denver, United States.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it